U.S. General Merchandise and Department Stores Stock News

NasdaqGS:LAES
NasdaqGS:LAESSemiconductor

SEALSQ (LAES) Reaffirms Growth Outlook Following Quantum Push As Fair Value Debate Builds

SEALSQ guidance and quantum roadmap draw investor focus SEALSQ (LAES) has reaffirmed its 2026 revenue guidance of 50% to 100% growth on audited 2025 revenue of US$18.3 million, while pushing ahead with its post-quantum cryptography product and readiness strategy. See our latest analysis for SEALSQ. Despite SEALSQ’s guidance reaffirmation and progress on its post quantum roadmap, the stock’s recent momentum has cooled, with the share price down 12.5% over 30 days and the year to date share...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

Is MercadoLibre (NasdaqGS:MELI) Trading At A Discount Or A Premium?

MercadoLibre’s share price has delivered a 61.7% gain over the past three years, yet its valuation signals are pulling in different directions, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market multiples suggest the stock trades at a premium. A 61.7% return over three years suggests MercadoLibre has already rewarded investors who stayed the course. This naturally raises the bar for what counts as good value today. Recent coverage...
NasdaqCM:SHAZ
NasdaqCM:SHAZIT

AI Small Cap Stocks Riding The Next Wave Of Compute And Voice Demand

With inflation, interest rate debates and energy shocks all pulling markets in different directions, investors are looking for clearer, more focused ideas. The AI Small Caps screener targets smaller companies that are building early-stage tools in areas such as machine learning, automation and data intelligence. These companies are at a stage where growth potential can still be influenced by new products and adoption. This article highlights 3 stocks from that screener, giving you a curated...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Pharmaceuticals (AUPH) Launches PRESERVE Study, Is A 5% Undervalued View Enough?

Aurinia Pharmaceuticals (AUPH) is drawing fresh attention after announcing PRESERVE, a Phase 4 multicenter study testing its oral lupus nephritis drug LUPKYNIS alongside three established immune therapies. See our latest analysis for Aurinia Pharmaceuticals. The PRESERVE announcement comes after a strong period for Aurinia Pharmaceuticals, with a 1 year total shareholder return of 113.70% and a more moderate 5.67% year to date share price return. This suggests momentum that investors are now...
NYSE:HRL
NYSE:HRLFood

Beyond Meat Stock And 2 Protein Plays To Watch After Brazilian Beef Tariff Relief

Global protein markets are being shaken by the Trump administration’s decision to exempt Brazilian beef from proposed 25% tariffs, and that ripple is reaching well beyond ranches. For investors, this kind of trade shock can quickly reshuffle pricing power, costs and demand across traditional meat producers and consumer protein alternatives. This article breaks down three stocks exposed to the news, highlighting one that could see a potential tailwind from shifting consumer preferences and two...
NasdaqGS:TLN
NasdaqGS:TLNRenewable Energy

Talen Energy Stock Is Drawing Fresh Attention After The Proxima Fusion Funding Round

Clean energy and advanced nuclear are back in the spotlight after Google, XTX Markets and others backed a €400mn funding round in fusion start-up Proxima Fusion, valuing it at €2.4bn. For investors, that kind of commitment from major tech and energy companies signals fresh attention on businesses tied to next generation power, data centers and supporting infrastructure. This article breaks down 3 stocks that appear positively exposed to this fusion driven news, helping you think through where...
NasdaqGS:ANAB
NasdaqGS:ANABBiotechs

Should AnaptysBio’s (ANAB) Russell Index Removal Prompt a Rethink of Its Liquidity and Investor Base?

In June 2026, AnaptysBio, Inc. was removed from several Russell indices, including the Russell Microcap, Russell 3000E, and related growth benchmark indices, triggering index rebalancing by passive funds. This broad removal from key Russell benchmarks may influence how investors perceive AnaptysBio’s visibility, liquidity, and role within the small-cap biotech universe. We’ll now examine how AnaptysBio’s exit from multiple Russell indices shapes its investment narrative, especially around...
NYSE:KSS
NYSE:KSSMultiline Retail

3 Stocks Retail Investors Should Watch As Tariffs Raise Pressure on 3M and Kohl's

Tariff headlines are back at the center of the market conversation, with President Trump pushing for broad new charges on imports from the EU and dozens of other countries, while legal challenges and rising costs for businesses add to the uncertainty. For investors, that kind of policy volatility tends to reward close attention to companies most exposed to shifting trade rules and imported inputs. This article breaks down three stocks from the Tariff Exposure Plays Amid Volatile US Trade...
NasdaqGS:BSY
NasdaqGS:BSYSoftware

Is Bentley Systems (BSY) Still Undervalued As Fresh Analyst Support Casts It As A Defensive AI Play?

Fresh coverage on Bentley Systems (BSY) is drawing attention after BNP Paribas and Bank of America highlighted the company as a potential defensive AI play, citing structural advantages in its core infrastructure software markets. See our latest analysis for Bentley Systems. Despite fresh coverage, Bentley Systems’ recent share price performance has been mixed, with the stock down about 7% over the past 90 days and the 1 year total shareholder return declining around 42%. This underlines why...
NYSE:TDG
NYSE:TDGAerospace & Defense

How Strong Aftermarket Cash Flows And an Earnings Beat At TransDigm Group (TDG) Has Changed Its Investment Story

Recently, TransDigm Group reported quarterly earnings of US$9.85 per share, surpassing consensus forecasts, while analysts highlighted its strong record of outperforming expectations and its high-margin, recurring aftermarket aerospace revenue base. An interesting angle is that analysts are increasingly focusing on TransDigm’s proprietary components and recurring aftermarket cash flows as key supports for its earnings resilience. We’ll now examine how this increasingly bullish earnings...
NasdaqGS:INVA
NasdaqGS:INVAPharmaceuticals

Innoviva (INVA) Leaves Russell Indexes, Is The Stock Still Cheap?

Index removal puts Innoviva in focus Innoviva (INVA) has just been dropped from several Russell growth and small cap benchmarks. This type of change can prompt index-tracking funds to rebalance and may lead to increased short term trading activity in the stock. See our latest analysis for Innoviva. At a share price of US$22.25, Innoviva has seen mixed momentum, with the share price return up 11.98% year to date but down over the past quarter. Longer term total shareholder returns of 16.74%...
NYSE:GBX
NYSE:GBXMachinery

Greenbrier (GBX) Is Down 6.6% After Weaker Q3 Earnings And Dividend Affirmation Has The Bull Case Changed?

The Greenbrier Companies, Inc. recently reported third-quarter 2026 results showing revenue of US$576.5 million and net income of US$18.9 million, both lower than the same period a year earlier, alongside weaker earnings per share from continuing operations. Despite softer earnings and the completion of a long-running buyback program, management affirmed a quarterly dividend of US$0.34 per share, signaling confidence while balancing shareholder returns with current operating conditions. With...
NasdaqGM:RDNT
NasdaqGM:RDNTHealthcare

RadNet (RDNT) Launches Reporting Pro, Is The Stock Still Undervalued?

RadNet (RDNT) is back in focus after its DeepHealth subsidiary commercially launched Reporting Pro, an AI powered radiology tool that combines speech recognition, AI generated findings, and quality checks within a single workflow. See our latest analysis for RadNet. Despite a 1-day share price return that declined 1.6% to about US$67.83, RadNet has seen strong short term momentum with a 7-day share price return of 10% and a 30-day share price return of 24.8%. The 1-year total shareholder...
NasdaqGS:INDV
NasdaqGS:INDVPharmaceuticals

Is Indivior Pharmaceuticals (INDV) Fully Valued As Russell 2000 Index Additions Draw Buyers?

Index additions put Indivior Pharmaceuticals in the spotlight Indivior Pharmaceuticals (INDV) has been added to the Russell 2000 Growth-Defensive, Value-Defensive, and Defensive indices, an event that can influence trading activity as index funds adjust their holdings. See our latest analysis for Indivior Pharmaceuticals. At a share price of US$40.83, Indivior Pharmaceuticals has seen a 90 day share price return of 27.83% and a 1 year total shareholder return of 169.15%. This suggests...
NasdaqGM:VERX
NasdaqGM:VERXSoftware

Vertex (VERX) Could Be 28% Undervalued As TD Cowen Backs Its Profit Plan

Vertex (VERX) drew fresh investor attention after TD Cowen initiated coverage, alongside the company’s recent first quarter beat, the Brinta e-invoicing acquisition and a new Value Creation Plan focused on profitability and free cash flow. See our latest analysis for Vertex. Vertex’s recent 1-day share price return of 4.28% and 7-day share price return of 16.72% suggest short term momentum is building. However, the year-to-date share price return of 29.51% and 1-year total shareholder return...
NasdaqGS:MKTX
NasdaqGS:MKTXCapital Markets

Should MarketAxess’ New AI Bond Data Feed TraX Tape Require Action From MarketAxess (MKTX) Investors?

MarketAxess Holdings Inc. recently launched TraX Tape, a bond market data solution that consolidates global trading activity into a single standardized feed enriched with real-time analytics and AI-powered pricing intelligence. By layering proprietary data cleansing, directional indicators, yield and spread calculations, and its CP+ pricing engine onto TraX Tape, MarketAxess is aiming to deliver cleaner fixed income data that could make electronic trading workflows more efficient for...
NasdaqGS:SLDB
NasdaqGS:SLDBBiotechs

Is Solid Biosciences (SLDB) Undervalued Following Its Russell Growth Index Additions?

Solid Biosciences (SLDB) has just been added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indices, an index reshuffle that can influence how some investors view the stock. See our latest analysis for Solid Biosciences. These index additions come after a strong run in Solid Biosciences' share price, with a 30 day share price return of 66.42% and a year to date share price return of 104.59%. The 1 year total shareholder return of 112.79%...
NYSE:FRO
NYSE:FROOil and Gas

Is Frontline (FRO) Still Cheap As Longer Tanker Routes Lift Earnings?

Iran’s renewed push to impose transit tolls in the Strait of Hormuz has reshaped key shipping routes, and Frontline (NYSE:FRO) is at the center of that shift after reporting earnings tied to longer tanker journeys. See our latest analysis for Frontline. At a share price of $37.66, Frontline’s recent momentum is clear, with a 1-day share price return of 2.14%, a 7-day share price return of 8.25%, and an 82.99% year-to-date share price return. The 1-year total shareholder return of 127.34% and...
NYSE:HLX
NYSE:HLXEnergy Services

Should Helix’s New Russell 2000 Defensive Index Status (HLX) Require Action From Investors?

On 27 June 2026, Helix Energy Solutions Group, Inc. (NYSE: HLX) was added to the Russell 2000 Defensive, Growth-Defensive, and Value-Defensive Indexes, boosting its profile among index-linked and institutional investors. This unusual inclusion across multiple Russell 2000 defensive sub-indexes highlights how Helix is now being classified as both growth- and value-oriented within a more defensive universe. Next, we’ll examine how this new Russell 2000 defensive index membership could...
NYSE:KRP
NYSE:KRPOil and Gas

How Kimbell Royalty Partners’ US$102 Million Shelf Registration At KRP Has Changed Its Investment Story

Kimbell Royalty Partners, LP recently filed a shelf registration statement for up to US$101.99 million, covering 6,929,000 common units, giving the partnership flexibility to issue equity in the future. This filing highlights management’s potential interest in future capital raising, which may influence how investors think about funding growth and possible unit dilution. We’ll now explore how this new shelf registration, and the possibility of future common unit issuance, could reshape...
NasdaqGM:NIPG
NasdaqGM:NIPGEntertainment

NIP Group (NIPG) Looks Pricey As Stock Split And Finance Exit Raise Fresh Questions

NIP Group (NIPG) is set for a 1-for-30.00003 stock split or significant stock dividend on July 6, 2026, shortly after the resignation of Director and Financial Director Ms. Yanjun Xu. See our latest analysis for NIP Group. At a latest share price of $7.79, NIP Group has seen its 30 day share price return fall 33.11% and its 1 year total shareholder return decline 87.58%. This suggests momentum has weakened ahead of the announced stock split and recent board change. If this kind of volatility...
NasdaqCM:AVTX
NasdaqCM:AVTXBiotechs

What Avalo Therapeutics (AVTX)'s Russell Index Additions and Board Refresh Mean for Shareholders

Avalo Therapeutics was recently added to multiple Russell indices and appointed veteran biopharma executive Ron Philip to its board, moves that follow positive Phase 2 data for its lead IL‑1β antibody abdakibart in hidradenitis suppurativa and preparation for investor meetings at the Leerink Partners Therapeutics Forum. Together, the index inclusions, strengthened governance, and focus on IL‑1β‑targeted therapies highlight how a once‑smaller biotech is gaining broader institutional...
NYSE:XPO
NYSE:XPOTransportation

Tariffs Could Reshape These US Logistics Stocks

Tariff shocks are back on the table, and this time the proposals reach across 60 economies, from key allies to major trade partners like China and India. For US transportation and logistics stocks, higher trade barriers can reshuffle supply chains, alter freight volumes, and change where value is created. That can create fresh pressure for some companies and new openings for others. This article looks at 3 stocks from a US Transportation and Logistics Companies screener that appear positioned...
NasdaqGS:TMUS
NasdaqGS:TMUSWireless Telecom

T Mobile (TMUS) Faces A New Opening As Dish Folds And 2G Ends

Dish Wireless has filed for Chapter 11 bankruptcy, reducing a direct rival in the U.S. wireless market. T-Mobile US plans to shut down its legacy 2G GSM network after 35 years of operation. These developments could affect T-Mobile's pricing power, customer mix, and network modernization timeline. T-Mobile US (NasdaqGS:TMUS) is seeing its competitive position reshaped just as its stock trades at $181.79. The company has posted a gain of 4.5% over the past week and 2.1% over the past month,...